Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | TGM2 | P21980 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GSTO1 | P78417 | 2/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL730210 | 0.84 | ALDH1A1 (0.53) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL7269650 | 0.83 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL28550144 | 0.82 | ALDH1A1 (0.51) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL28266739 | 0.82 | HDAC3 (0.42) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL5396951 | 0.81 | ALDH1A1 (0.58) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL30758297 | 0.78 | CYP2C19 (0.59) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL10594826 | 0.78 | CYP2C19 (0.59) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL26605882 | 0.77 | KCNN4 (0.44) | ALDH1A1CYP3A4CYP2C19TSHRKMT2A | |
| SCHEMBL7868749 | 0.77 | ALDH1A1 (0.54) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL10825012 | 0.76 | KCNN4 (0.48) | ALDH1A1CYP3A4CYP2C19TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-12-25 | — | — | US | claimed |
| US-20250298042-A1 | ENGINEERED PARTICLES AS RED BLOOD CELL MIMICS AND COMPOSITIONS CONTAINING SAME FOR HEMATOLOGY | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-09-25 | — | — | US | claimed |
| EP-4608872-A2 | SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION | Slingshot Biosciences, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-12379387-B2 | Engineered particles as red blood cell mimics and compositions containing same for hematology | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-08-05 | — | — | US | claimed |
| EP-3256850-B1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES INC (US) | 2025-07-09 | — | — | EP | claimed |
| US-12352679-B2 | Synthetic human cell mimic particle for cytometric or coulter device | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-07-08 | — | — | US | claimed |
| EP-4577823-A2 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | Slingshot Biosciences, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| US-20250189428-A1 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-06-12 | — | — | US | claimed |
| US-12312595-B2 | Hydrogel particles as feeder cells and as synthetic antigen presenting cells | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-05-27 | — | — | US | claimed |
| US-20250164373-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-05-22 | — | — | US | claimed |
| US-20160258856-A1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES, INC. | 2016-09-08 | — | — | US | claimed |
| WO-2016130489-A1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES, INC. (US) | 2016-08-18 | — | — | WO | claimed |
| US-6673886-B2 | FOR INTRAOCULAR LENSES | BAUSCH & LOMB INCORPORATED | 2004-01-06 | — | — | US | claimed |
| US-6657030-B2 | High refractive index and hydrophilic monomers, a crosslinker, an initiator and water | BAUSCH & LOMB INCORPORATED | 2003-12-02 | — | — | US | claimed |
| US-20020049290-A1 | High refractive index hydrogel compositions for ophthalmic implants | VANDERBILT DAVID P (US) | 2002-04-25 | — | — | US | claimed |
| US-20020042483-A1 | High refractive index hydrogel compositions for ophthalmic implants | VANDERBILT DAVID P (US) | 2002-04-11 | — | — | US | claimed |
| US-20020042484-A1 | High refractive index hydrogel compositions for ophthalmic implants | BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) | 2002-04-11 | — | — | US | claimed |
| US-20020037984-A1 | High refractive index hydrogel compositions for ophthalmic implants | VANDERBILT DAVID P (US) | 2002-03-28 | — | — | US | claimed |
| US-6329485-B1 | FOR INTRAOCULAR LENSES | BAUSCH & LOMB INCORPORATED | 2001-12-11 | — | — | US | claimed |
| WO-2000034804-A1 | HIGH REFRACTIVE INDEX HYDROGEL COMPOSITIONS FOR OPHTHALMIC IMPLANTS | BAUSCH & LOMB SURGICAL, INC. (US) | 2000-06-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | CD4, ICOS, CD69 | ALDH1A1 3752/4885CYP3A4 3134/4885CYP2C9 2241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.